A patient who is on LMWH, suddenly develops hemorrhage, next step is
**Core Concept**
Low Molecular Weight Heparin (LMWH) is a type of anticoagulant that inhibits Factor Xa and to a lesser extent, thrombin. It is commonly used in the treatment and prevention of deep vein thrombosis and pulmonary embolism. The management of LMWH-induced bleeding is crucial to prevent further complications.
**Why the Correct Answer is Right**
In the event of LMWH-induced bleeding, the next step is to stop the anticoagulant therapy. This is because LMWH has a long half-life and can accumulate in the body, prolonging the bleeding time. Discontinuing the LMWH allows the body to clear the anticoagulant and reduces the risk of further bleeding. The patient should also be monitored for signs of bleeding and receive supportive care as needed.
**Why Each Wrong Option is Incorrect**
* **Option A:** Administering fresh frozen plasma (FFP) is not the next step in managing LMWH-induced bleeding. FFP may be used to reverse warfarin-induced bleeding but is not effective in reversing LMWH.
* **Option B:** Activated charcoal is not indicated in the management of LMWH-induced bleeding. Charcoal is used to adsorb oral medications but is not effective in reversing anticoagulant effects.
* **Option C:** Protamine sulfate is used to reverse unfractionated heparin (UFH) but not LMWH. Protamine can bind to UFH and neutralize its anticoagulant effects, but it is not effective against LMWH.
**Clinical Pearl / High-Yield Fact**
LMWH-induced bleeding is a medical emergency that requires prompt recognition and management. The key to managing LMWH-induced bleeding is to stop the anticoagulant therapy and provide supportive care as needed.
**Correct Answer:** D.